214 related articles for article (PubMed ID: 37169747)
1. Detecting recurrent passenger mutations in melanoma by targeted UV damage sequencing.
Selvam K; Sivapragasam S; Poon GMK; Wyrick JJ
Nat Commun; 2023 May; 14(1):2702. PubMed ID: 37169747
[TBL] [Abstract][Full Text] [Related]
2. High UV damage and low repair, but not cytosine deamination, stimulate mutation hotspots at ETS binding sites in melanoma.
Duan M; Song S; Wasserman H; Lee PH; Liu KJ; Gordân R; He Y; Mao P
Proc Natl Acad Sci U S A; 2024 Jan; 121(4):e2310854121. PubMed ID: 38241433
[TBL] [Abstract][Full Text] [Related]
3. Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers.
Elliott K; Boström M; Filges S; Lindberg M; Van den Eynden J; Ståhlberg A; Clausen AR; Larsson E
PLoS Genet; 2018 Dec; 14(12):e1007849. PubMed ID: 30586386
[TBL] [Abstract][Full Text] [Related]
4. ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma.
Mao P; Brown AJ; Esaki S; Lockwood S; Poon GMK; Smerdon MJ; Roberts SA; Wyrick JJ
Nat Commun; 2018 Jul; 9(1):2626. PubMed ID: 29980679
[TBL] [Abstract][Full Text] [Related]
5. Genomic sites hypersensitive to ultraviolet radiation.
Premi S; Han L; Mehta S; Knight J; Zhao D; Palmatier MA; Kornacker K; Brash DE
Proc Natl Acad Sci U S A; 2019 Nov; 116(48):24196-24205. PubMed ID: 31723047
[TBL] [Abstract][Full Text] [Related]
6. [Ultraviolet A-induced DNA damage: role in skin cancer].
Beani JC
Bull Acad Natl Med; 2014 Feb; 198(2):273-95. PubMed ID: 26263704
[TBL] [Abstract][Full Text] [Related]
7. CTCF binding modulates UV damage formation to promote mutation hot spots in melanoma.
Sivapragasam S; Stark B; Albrecht AV; Bohm KA; Mao P; Emehiser RG; Roberts SA; Hrdlicka PJ; Poon GMK; Wyrick JJ
EMBO J; 2021 Oct; 40(20):e107795. PubMed ID: 34487363
[TBL] [Abstract][Full Text] [Related]
8. Genome-Wide Mapping of UV-Induced DNA Damage with CPD-Seq.
Mao P; Wyrick JJ
Methods Mol Biol; 2020; 2175():79-94. PubMed ID: 32681485
[TBL] [Abstract][Full Text] [Related]
9. The major mechanism of melanoma mutations is based on deamination of cytosine in pyrimidine dimers as determined by circle damage sequencing.
Jin SG; Pettinga D; Johnson J; Li P; Pfeifer GP
Sci Adv; 2021 Jul; 7(31):. PubMed ID: 34330711
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide profiles of UV lesion susceptibility, repair, and mutagenic potential in melanoma.
Perez BS; Wong KM; Schwartz EK; Herrera RE; King DA; García-Nieto PE; Morrison AJ
Mutat Res; 2021; 823():111758. PubMed ID: 34333390
[TBL] [Abstract][Full Text] [Related]
11. Recurrent Noncoding Mutations in Skin Cancers: UV Damage Susceptibility or Repair Inhibition as Primary Driver?
Roberts SA; Brown AJ; Wyrick JJ
Bioessays; 2019 Mar; 41(3):e1800152. PubMed ID: 30801747
[TBL] [Abstract][Full Text] [Related]
12. UV wavelength-dependent DNA damage and human non-melanoma and melanoma skin cancer.
Pfeifer GP; Besaratinia A
Photochem Photobiol Sci; 2012 Jan; 11(1):90-7. PubMed ID: 21804977
[TBL] [Abstract][Full Text] [Related]
13. Nucleosome positions establish an extended mutation signature in melanoma.
Brown AJ; Mao P; Smerdon MJ; Wyrick JJ; Roberts SA
PLoS Genet; 2018 Nov; 14(11):e1007823. PubMed ID: 30485262
[TBL] [Abstract][Full Text] [Related]
14. Atypical UV Photoproducts Induce Non-canonical Mutation Classes Associated with Driver Mutations in Melanoma.
Laughery MF; Brown AJ; Bohm KA; Sivapragasam S; Morris HS; Tchmola M; Washington AD; Mitchell D; Mather S; Malc EP; Mieczkowski PA; Roberts SA; Wyrick JJ
Cell Rep; 2020 Nov; 33(7):108401. PubMed ID: 33207206
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide impact of cytosine methylation and DNA sequence context on UV-induced CPD formation.
Wilson HE; Wyrick JJ
Environ Mol Mutagen; 2024 Apr; 65 Suppl 1(Suppl 1):14-24. PubMed ID: 37554110
[TBL] [Abstract][Full Text] [Related]
16. A streamlined solution for processing, elucidating and quality control of cyclobutane pyrimidine dimer sequencing data.
Sheng Q; Yu H; Duan M; Ness S; He J; Kang H; Jiang L; Wyrick JJ; Mao P; Guo Y
Nat Protoc; 2021 Apr; 16(4):2190-2212. PubMed ID: 33731963
[TBL] [Abstract][Full Text] [Related]
17. Cyclobutane Pyrimidine Dimer Hyperhotspots as Sensitive Indicators of Keratinocyte UV Exposure
Garcia-Ruiz A; Kornacker K; Brash DE
Photochem Photobiol; 2022 Sep; 98(5):987-997. PubMed ID: 35944237
[TBL] [Abstract][Full Text] [Related]
18. Analysis of SDHD promoter mutations in various types of melanoma.
Scholz SL; Horn S; Murali R; Möller I; Sucker A; Sondermann W; Stiller M; Schilling B; Livingstone E; Zimmer L; Reis H; Metz CH; Zeschnigk M; Paschen A; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
Oncotarget; 2015 Sep; 6(28):25868-82. PubMed ID: 26327518
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of DNA repair using topical T4 endonuclease V does not inhibit melanoma formation in Cdk4(R24C/R24C)/Tyr-Nras(Q61K) mice following neonatal UVR.
Hacker E; Muller HK; Hayward N; Fahey P; Walker G
Pigment Cell Melanoma Res; 2010 Feb; 23(1):121-8. PubMed ID: 19788533
[TBL] [Abstract][Full Text] [Related]
20. TERT promoter mutation status as an independent prognostic factor in cutaneous melanoma.
Griewank KG; Murali R; Puig-Butille JA; Schilling B; Livingstone E; Potrony M; Carrera C; Schimming T; Möller I; Schwamborn M; Sucker A; Hillen U; Badenas C; Malvehy J; Zimmer L; Scherag A; Puig S; Schadendorf D
J Natl Cancer Inst; 2014 Sep; 106(9):. PubMed ID: 25217772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
